A business in context

ABCL research notebook

Read the disclosures. Follow the relationships. Keep the dates in view.

Research JSON

Filing timeline

Download filings CSV

SEC submissions · retrieved 2026-10-20 · 8029 issuers; up to 32 recent company reports and 8 ownership-change filings per issuer

  1. 4 · Ownership change

    Report date 2026-08-24 · 0001628280-26-058684

  2. 4 · Ownership change

    Report date 2026-08-18 · 0001834423-26-000008

  3. 4 · Ownership change

    Report date 2026-08-14 · 0001834411-26-000008

  4. 4 · Ownership change

    Report date 2026-08-12 · 0001628280-26-057007

  5. 4 · Ownership change

    Report date 2026-08-11 · 0001628280-26-056653

  6. 8-K · Current report

    Report date 2026-08-12 · 0001193125-26-349353 · Items 1.01,8.01,9.01

  7. 8-K · Current report

    Report date 2026-08-10 · 0001703057-26-000053 · Items 7.01,9.01

  8. 8-K · Current report

    Report date 2026-08-07 · 0001703057-26-000049 · Items 8.01,9.01

  9. 10-Q · Quarterly report

    Report date 2026-06-30 · 0001703057-26-000046

  10. 8-K · Current report

    Report date 2026-08-05 · 0001703057-26-000044 · Items 2.02,7.01,9.01

  11. 8-K · Current report

    Report date 2026-07-29 · 0001703057-26-000039 · Items 8.01,9.01

  12. 8-K · Current report

    Report date 2026-06-30 · 0001703057-26-000037 · Items 5.02,9.01

  13. 4 · Ownership change

    Report date 2026-07-01 · 0001628280-26-047400

  14. 4 · Ownership change

    Report date 2026-07-01 · 0001628280-26-047396

  15. 8-K · Current report

    Report date 2026-06-17 · 0001703057-26-000035 · Items 8.01,9.01

  16. 4 · Ownership change

    Report date 2026-06-11 · 0001834423-26-000006

  17. 8-K · Current report

    Report date 2026-06-11 · 0001703057-26-000033 · Items 5.07

  18. 8-K · Current report

    Report date 2026-06-01 · 0001703057-26-000031 · Items 5.02,9.01

  19. 10-Q · Quarterly report

    Report date 2026-03-31 · 0001703057-26-000028

  20. 8-K · Current report

    Report date 2026-05-11 · 0001703057-26-000027 · Items 2.02,7.01,9.01

  21. DEF 14A · Proxy statement

    Report date 2025-12-31 · 0001703057-26-000020

  22. 10-K · Annual report

    Report date 2025-12-31 · 0001703057-26-000012

  23. 8-K · Current report

    Report date 2026-02-24 · 0001703057-26-000010 · Items 2.02,7.01,9.01

  24. 8-K · Current report

    Report date 2026-01-12 · 0001703057-26-000003 · Items 7.01,9.01

  25. 8-K · Current report

    Report date 2025-12-18 · 0001703057-25-000034 · Items 7.01,9.01

  26. 8-K · Current report

    Report date 2025-11-24 · 0001703057-25-000032 · Items 4.01,9.01

  27. 8-K · Current report

    Report date 2025-11-10 · 0001703057-25-000029 · Items 5.02,9.01

  28. 10-Q · Quarterly report

    Report date 2025-09-30 · 0001703057-25-000025

  29. 8-K · Current report

    Report date 2025-11-06 · 0001703057-25-000024 · Items 2.02,7.01,9.01

  30. 8-K · Current report

    Report date 2025-09-10 · 0001703057-25-000018 · Items 8.01,9.01

  31. 10-Q · Quarterly report

    Report date 2025-06-30 · 0001703057-25-000011

  32. 8-K · Current report

    Report date 2025-08-07 · 0001628280-25-038927 · Items 2.02,7.01,9.01

  33. 8-K · Current report

    Report date 2025-06-12 · 0001628280-25-031219 · Items 5.07

  34. 8-K · Current report

    Report date 2025-05-30 · 0001628280-25-028529 · Items 8.01,9.01

  35. 8-K · Current report

    Report date 2025-05-14 · 0001628280-25-025573 · Items 8.01,9.01

  36. 8-K · Current report

    Report date 2025-05-12 · 0001628280-25-025006 · Items 8.01,9.01

  37. 10-Q · Quarterly report

    Report date 2025-03-31 · 0001628280-25-023836

  38. 8-K · Current report

    Report date 2025-05-08 · 0001628280-25-023808 · Items 2.02,7.01,9.01

  39. DEF 14A · Proxy statement

    Report date 2024-12-31 · 0001628280-25-020703

  40. 10-K · Annual report

    Report date 2024-12-31 · 0001628280-25-008689

Reported insider transactions

Download transactions CSV

SEC insider transactions · retrieved 2026-10-15 · 2026 Q3: filings in this completed quarter; not a live transaction feed

Purchases and sales include open-market or private transactions. Grants, exercises and tax withholding are shown separately. Amendments and joint reports can overlap; rows are not a net-buying score. Prices retain the filing's units; consult its footnotes.

Transaction rows by code · counts, not monetary totals
Purchase: 4 transaction rows4PSale: 0 transaction rows0SGrant / award: 2 transaction rows2AExercise / conversion: 0 transaction rows0MTax / exercise payment: 0 transaction rows0FGift: 1 transaction rows1G
P · PurchaseS · SaleA · Grant / awardM · Exercise / conversionF · Tax / exercise paymentG · Gift

7 matching transaction rows.

Transaction / filedReporting ownerTypeSecuritySharesReported price
2026-08-24
2026-08-24
Hayden Michael RP · Purchase
Acquired
Common Shares53613.010.64
2026-08-18
2026-08-18
Montalbano John S.P · Purchase
Acquired
Common Shares10000.011.03
2026-08-14
2026-08-14
Booth AndrewP · Purchase
Acquired
Common Shares37200.010.32
2026-08-12
2026-08-14
Hayden Michael RP · Purchase
Acquired
Common Shares46387.010.37
2026-08-11
2026-08-13
Hayden Michael RG · Gift
Disposed
Common Shares50000.00.0
2026-07-01
2026-07-06
Seely LynnA · Grant / award
Acquired
Share option (right to buy)
Derivative security
152207.00.0
2026-07-01
2026-07-06
Sandor VictorA · Grant / award
Acquired
Share option (right to buy)
Derivative security
152207.00.0

Identity & relationships

Wikidata structured data · retrieved 2026-10-15 · 1663 unambiguous CIK-linked entities; coverage is incomplete

These are sourced identity and relationship claims, with incomplete coverage. Headquarters locations do not describe sales, assets or operating exposure.

SEC issuer · 0001703057AbCellera Biologics Inc.

No parent relationship is available in this import; this is not proof of independence.

No verified LEI join available.

GLEIF legal entity reference data · retrieved 2026-10-15 · 1199 checked identities; 0 unavailable records

Search names and former names

    Revenue in constant purchasing power

    USD revenue expressed in 2026-09 consumer-price dollars. Each annual period uses a CPI-U average weighted by the days in its actual reporting interval. This is a purchasing-power comparison, not a company-specific price or volume measure.

    Year endedReported USD revenueCPI-adjusted USD revenue
    2024-12-31$28.83M$30.97M
    2023-12-31$38.02M$42.05M
    2022-12-31$485.42M$558.79M
    2021-12-31$375.20M$466.47M
    2020-12-31$233.16M$303.54M
    2019-12-31$11.61M$15.30M

    Bureau of Labor Statistics · retrieved 2026-10-20 · 9 selected series; gaps remain missing

    Explore the CPI history ↗